• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4641089)   Today's Articles (4158)   Subscriber (50405)
For: El-Enbaby AM, Moneim NAAE, Khedr GAEA, Elwany YMN. Nine months versus 12 months of adjuvant trastuzumab for patients with HER2-positive breast cancer. Korean J Clin Oncol 2018;14:108-115. [DOI: 10.14216/kjco.18019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/06/2018] [Accepted: 11/12/2018] [Indexed: 09/01/2023]
Number Cited by Other Article(s)
1
A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer. Am J Clin Oncol 2020;43:510-516. [DOI: 10.1097/coc.0000000000000699] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA